Affinity Asset Advisors, LLC - 03 Apr 2025 SCHEDULE 13G Report for Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share (KPTI)

Filing Manager: Affinity Asset Advisors, LLC
Reporting Manager: Affinity Healthcare Fund, LP
Security: Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share
Symbol: KPTI
Shares outstanding: 8,483,065 shares
Disclosed Ownership: 664,224 shares
Ownership: 7.8%
Form type: SCHEDULE 13G
Filing time: 10 Apr 2025, 17:23:42 UTC
Date of event: 03 Apr 2025
Next filing: 29 Jan 2026
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Affinity Healthcare Fund, LP	7.8%	664,224	0	664,224	/s/ Andrew Weinstein	Andrew Weinstein
Affinity Asset Advisors, LLC	7.8%	664,224	0	664,224	/s/ Andrew Weinstein	Andrew Weinstein